Document:

Exhibit 10.105

 

CONSULTING AGREEMENT

 

This Agreement (“Agreement”) is made and effective Monday, January 1, 2013 by and between
BlueWater Advisory Group, LLLC, (“BlueWater”) and VG Life Sciences, Inc., (the “Company”).

 

Now, therefore, BlueWater and Company agree as follows:

 

		1.	VRAL shall retain the services of BlueWater, as investor
relations and as public relations consultant to do the following:

 

		a.	In consultation with management and the board of directors
of the Company, determine appropriate strategic investment thesis which will serve to guide the development of the Company’s
financial marketing, outreach and visibility enhancement program for the Company’s publicly traded shares, facilitate an
orderly market and bring activity to the market for the Company’s shares.

		b.	Drafting of an executive summary / corporate profile for
use in generating interest in the Company’s publicly traded shares and for use in raising additional capital to fund the
Company’s next stage of development.

		c.	Development and implementation of a complete investor relations
campaign to include:

		i.	News release timeline and news releases

		1.	Drafting of news releases to be crafted in an iterative
fashion in concert with executive officers of the Company and/or their designees

		ii.	Revision of copy for the Company’s website that incorporates
the investment thesis, especially the “Investor Section” of website and creation of a corporate newsletter, and also
creation of mechanism for collecting opt-in email addresses.

		iii.	Creation and scheduling of media opportunities in appropriate
trade and financial publications including online and blog opportunities.

		d.	Introduction to accredited investors experienced in early
stage, micro-cap investing.

		e.	Ongoing updates and reports relating to corporate developments
and dissemination of same.

 

2. BlueWater acknowledges that the determination of whether or not to issue any press release or
in engage in any investor relations or public relations company or activity shall be made by the Company in its sole
discretion. BlueWater agrees that in the performance of its services hereunder it shall follow the directions of the Company.

 

3. BlueWater shall provide services to the Company pursuant to this Agreement for a term commencing
on the date of this Agreement and ending six (6) months from date of this Agreement, subject to the termination as provided
for in Section 7 hereof.

 

    	1

    	 

    

 

 

4. The Company shall pay BlueWater $4500.00 a month of which a minimum of $1500.00 is payable in cash;
if the balance is to be paid in shares of VG LifeSciences, the $3000.00 balance will be paid in number of shares equal to a
value of two time (2X) the value of the balance due, (share price to be determined as the average of the closing price of the
Company’s Common Stock (on the principal exchange or market in which the Company’s Common Stock trades) for the
fourteen (14) trading days prior end of each month, effective January 1, 2013. Additionally, Company shall pay BlueWater and
additional 1700 shares of 144 stock from the Company, certificate to be delivered within 30 days of the date of engagement.
Additionally, BlueWater will receive 1700 warrants exercisable into shares of the Company common stock at $0.05 per share.

 

BlueWater and the Company agree that the Shares issuable pursuant to this Agreement to BlueWater
are nonrefundable, except if this Agreement is terminated prior to the end of the Term by the Company due to the breach of
this Agreement by BlueWater. For purposes of determining the holding period of Rule 144(d)(1) promulgated under the
Securities Act of 1933, as amended, the shares of common stock issuable pursuant to this contract shall be deemed fully paid
for upon the execution of this Agreement by the parties hereto. BlueWater shall not, without the prior written consent of the
Company, disclose to anyone any Confidential Information. “Confidential Information” for the purposes of this
Agreement shall include the Company proprietary and confidential information such as, but not limited to, customer lists,
business plans, marketing plans and financial information. Confidential Informatioin shall not include any information that
(A) is disclosed by the Company without restriction, (B) becomes publicly available through no act of BlueWater or (C) is
rightfully received by BlueWater from a third party, who to BlueWater’s knowledge, after reasonable inquiries, is bound
by a confidentiality agreement or duty to the Company. BlueWater has signed a Non-Disclosure Agreement, which is integrated
by reference into this Agreement.

 

6. BlueWater specifically shall not, during the drafting and editing phase of the creation of
the document, share the contents of any press releases or other documents, with any other consultants or investors, or
potential investors. BlueWater will operate under strict adherence to all disclosure requirements. In performing its
obligations hereunder, BlueWater shall strictly comply with all applicable laws, regulations and rules, including, without
limitation, the rules and regulations of the Securities an Exchange Commission.

 

7. This Agreement may be terminated, by either party, prior to the end of the six (6) month term of this
Agreement upon a breach of this Agreement by the other party which breach is not fully cured within ten (10) days
after written notice of breach from the non-breaching party. If this Agreement is terminated by the Company due to a breach
by BlueWater, without limiting the Company’s other rights and remedies arising from such breach, BlueWater will be
obligated to refund a pro rata portion of the consideration paid to BlueWater pursuant to Section 4 hereor, based upon the
timing of the termination.

 

8. BlueWater is and throughout this Agreement shall be an independent contractor and not an employee,
partner or agent of the Company. BlueWater shall not be entitled to nor receive any benefit normally provided to the
Company’s employees such as, but not limited to, vacation payment, retirement, health care or sick pay. The
Company shall not be responsible for withholding income or other taxes from the payments made to BlueWater. BlueWater shall
be solely responsible for filing all returns and paying any income, social security or other tax levied upon or determined
with respect to the payments made to BlueWater pursuant to this Agreement and BlueWater agrees to indemnify the Company and
hold the Company harmless from any claim that the Company is responsible for the payment of any taxes on the Compensation
received by BlueWater pursuant to this Agreement.

 

    	2

    	 

    

 

 

9. Unless otherwise agreed to in writing by the Company in advance, BlueWater shall be
solely responsible for procuring, paying for and maintaining any computer equipment, sofware, paper, tools or supplies
necessary or appropriate for the performance of BlueWater’s services hereunder and all other cost and expenses incurred
by BlueWater in performing its services hereunder. Certain expenses are to be paid by the Company, including but not limited
to, issuance of press releases; pre-approved travel on behalf of the company; costs associated with road show and other
events and activities designed to raise awareness of the company’s business plan and growth strategy.

 

10. This Agreement shall be governed by and construed in accordance with the laws of the State of
California, with regard or reference to its conflict of law principle.

 

11. The headings in this Agreement are inserted for convenience only and shall not be used to define,
limit or describe the scope of this Agreement or any of the obligations herein.

 

12. This Agreement constitutes the final understanding and agreement between the parties with respect
to the subject matter hereof and supersedes all prior negotiations, understandings and agreements between the parties,
whether written or oral all of which are merged herein. This Agreement may be amended, supplemented or changed only by an
agreement in writing signed by both of the parties.

 

13. Any notice required to be given or otherwise given pursuant to this Agreement shall be in writing
and shall be hand delivered, mailed by certified mail, return receipt requested or sent by recognized overnight courier service.

 

14. If any term of this Agreement is held by a court of competent jurisdiction to be invalid or
unenforceable, then this Agreement, including all of the remaining terms, shall remain in full force and effect as if such
invalid or unenforceable term had never been included.

 

IN WITNESS WHEREOF, this Agreement has been executed by the parties as of the date first written above.

 

	BlueWater Advisory Group (“BlueWater”)	 	VG Life Sciences Inc “Company”
	Two Skyline Circle	 	2290 Huntington Drive, Suite 100
	Santa Barbara, CA 93109	 	San Marino, CA 91108
	 	 	 
	/s/ signature	 	/s/ Haig Keledjian
	Bryan G. Crane, Managing Director	 	Haig Keledjian, CEO

 

 

    	3Exhibit 10.106

 

 

NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT),
AND ACCORDINGLY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
THIS NOTE DOES NOT REQUIRE PHYSICAL SURRENDER HEREOF IN ORDER TO EFFECT A PARTIAL PAYMENT, REDEMPTION, OR CONVERSION HEREOF. ACCORDINGLY,
THE OUTSTANDING PRINCIPAL AMOUNT OF THIS Note MAY BE LESS THAN THE PRINCIPAL AMOUNT SHOWN BELOW.

VG LIFE SCIENCES INC.

CONVERTIBLE NOTE

	San Marino, California Issue Date: January 1, 2013	
        $3,535

        Maturity Date: December 31, 2014

 

FOR
VALUE RECEIVED, VG Life Sciences Inc., a Delaware corporation formerly known as Viral Genetics, Inc., whose address is 2290
Huntington Drive, Suite 100, San Marino, California, 91108, ("Borrower"), promises to pay to or to the order
of Michael Capizzano ("Lender"), and his successors and assigns, in lawful money of the United States of America,
three thousand and five hundred and thirty-five dollars ($3,535) (the "Principal"), without interest. This Convertible
Note (the "Note") is issued in satisfaction of expenses due to Lender by Borrower, as listed in Exhibit A (the "Expenses").

 

	1.		Payment and Conversion.

 

	(a)		Payment. Borrower shall pay to Lender the Principal under this Note on or before
the Maturity Date affixed above. Borrower shall pay all amounts due under this Note in lawful money of the United States of America
and without set-off, deduction, demand or notice.

	(b)		Exchange of Loan Obligation. All or any portion of the then outstanding Principal
("Exchanged Amount") may be exchanged for shares of Borrower's common stock ("Shares") at the election of
either Lender or Borrower at any time prior to the Maturity Date by giving written notice in the form attached as Annex
A (a "Notice of Conversion"), subject to the limitations set forth in Section 1(d) below (a "Conversion").
In return for the Exchanged Amount so exchanged, Lender shall receive a number of Shares equal to the Exchanged Amount
divided by the Exchange Price. The Exchange Price shall be equal to the lesser of (x) 80% of the volume-weighted average closing
price of the Borrower's common stock for the twenty (20) trading days immediately prior to the date of the Notice of Conversion
(the "Exchange Date") as reported on the OTCBB, Pinksheets, or other market where the Shares are then quoted for trading
provided that in the event no such quoted market exists, the Exchange Price shall be determined according to an appraisal of fair
market value conducted by a mutually-agreed independent appraiser, and ratified by the disinterested members of the Borrower's
board of directors or if there are no disinterested members then the board acting unanimously; and (y) $0.14 (which shall be adjusted
proportionately or as appropriate in the event of any stock split, recapitalization, stock dividend or other similar transaction).

 

An election made to exchange amounts owed
hereunder for Shares cannot be revoked without the written consent of the other party. The Borrower shall issue and deliver
to the Lender the Shares by DWAC within not more than one (1) business day of receiving notice from Lender. Should such
Notice of Conversion represent all of the remaining obligations due hereunder, Lender shall deliver to Borrower the original
Note marked "paid in full."

    	1

    	 

    

	(c)		Mandatory Conversion. Any unpaid Principal due hereunder upon the Maturity
Date shall automatically be exchanged for Shares upon the terms described in Section above using the Maturity Date as the Exchange
Date, without requiring the additional consent of either party, provided that the restrictions described in Section 1(d) below
are observed.

	(d)		Restrictions on Conversion.

	i)		4.99% Limitation. Under no circumstances may either Lender or Borrower effect
a Conversion if, after giving effect to such Conversion upon delivery of Shares, Borrower would beneficially own in excess of
4.99% of the Shares of Lender outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence,
the number of Shares beneficially owned by the Lender and its Affiliates (as defined below) shall include the number of Shares
issuable upon the Conversion with respect to which the determination of such sentence is being made, but shall exclude the number
of Shares which would be issuable upon (A) conversion of the remaining, nonconverted portion of this Note beneficially owned by
the Lender or any of its Affiliates and (B) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Borrower (including, without limitation, any other Notes or the Warrants) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Lender or any of its Affiliates. Except as set forth in
the preceding sentence, for purposes of this Section 1(d)(i), beneficial ownership shall be calculated in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder and the rules and
regulations promulgated thereunder (the "Exchange Act"). To the extent that the limitation contained in this section
applies, the determination of whether this Note is convertible (in relation to other securities owned by the Lender) and of which
a portion of this Note is convertible shall be in the sole discretion of Lender. To ensure compliance with this restriction, Lender
will be deemed to represent to the Borrower each time it delivers a Notice of Conversion that such Notice of Conversion has not
violated the restrictions set forth in this paragraph and the Borrower shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(d)(i),
in determining the number of outstanding Shares, the Lender may rely on the number of outstanding Shares as reflected in (x) the
Borrower's most recent quarterly or annual report on Form 10-QSB or Form 10-KSB or equivalent similar filing on such public disclosure
service as the Borrower may then be utilizing, as the case may be, (y) a more recent public announcement by the Borrower including
on the OTC Markets website, or (z) any other notice by the Borrower or the Borrower's Transfer Agent approved by the Borrower
setting forth the number of Shares outstanding. Upon the written or oral request of the Lender, the Borrower shall within two
business days confirm orally and in writing to the Lender the number of Shares then outstanding. In any case, the number of outstanding
Shares shall be determined after giving effect to the conversion or exercise of securities of the Borrower, including this Note,
by the Lender or its Affiliates since the date as of which such number of outstanding Shares was reported. The provisions of this
Section 1(d) may be waived by the Lender, at the election of the Lender, upon not less than 61 days' prior notice to the Borrower,
and the provisions of this Section 1(d)(i) shall continue to apply

 

    	2

    	 

    

 

 

	ii)		until such 61st day (or such later date, as determined by the Lender, as may be specified
in such notice of waiver). The provisions of this paragraph shall be implemented in a manner necessary to preserve the intended
4.99% beneficial ownership limitation herein contained and shall not be modified in a manner otherwise than in strict conformity
with the terms of this Section 1(d)(i) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended 4.99% beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such 4.99% limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Note. "Affiliate" means any Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144 under the
Securities Act of 1933, as amended.

	ii		Conversion by Borrower. In addition to the limitations imposed by Section 1(d)(i)
above, 
 Borrower may only exercise their right to effect a Conversion of Principal by Lender if all of the following
are true:

	a.		the Shares that Lender would receive are, upon receipt, freely-tradable and may be
sold or transferred by Lender without restriction on resale of any kind;

	b.		the Shares are listed or quoted for trading on the OTCBB, Pinksheets or an equivalent
recognized exchange;

	c.		at the time of delivery of the Shares, the Borrower is in good standing as a publicly
traded entity, meeting all requirements for providing "adequate current information" or maintaining "fully-reporting"
status as those terms are used in the ordinary course of business, and is otherwise in good standing under applicable securities
law, exchange rules or similar rules or regulations, including, without limitation possessing no less than a "Pink Current"
sign if trading on the Pinksheets market; and

	d.		no Event of Default exists (as defined below).

	2.		Interest. This Note shall not bear interest.

	3.		Application of Payments. Payments will be applied first to any costs and expenses
(including reasonable attorneys' fees) incurred by Lender in connection with the collection of amounts owing pursuant to this
Note, then to interest accruing at the Default Rate, and then to reduction of Principal. All payments shall be made to Lender
at the specified address until receipt of notice from Lender to the contrary.

	4.		Default Rate. Upon the occurrence of an Event of Default, Lender shall be entitled
to receive, and Borrower shall pay to Lender, interest on the outstanding principal balance and any other advances or charges
advanced by Lender at a per annum rate equal to the lesser of (a) eighteen percent (18%), or (b) the maximum interest rate which
Borrower may by law pay (the "Default Rate"). The Default Rate shall be computed from the occurrence of the Event
of Default until the earlier of the date upon which the Event of Default is cured or the date upon which due and owing under this
Note are paid in full. The preceding sentence, however, shall not be construed as an agreement or privilege to extend the date
of the any payment due hereunder, or as a waiver of any other right or remedy accruing to Lender by reason of the occurrence
of any Event of Default.

	5.		Prepayment. This Note may be prepaid by providing twenty business days' notice
during which time Lender may exercise their right to effect a Conversion.

	6.		Security
                                         Interest. This Note is unsecured.

 

    	3

    	 

    

 

	7.		Default. Any one of the following occurrences shall constitute an "Event
of Default" under this Unsecured Revolving Credit Note provided that Lender shall be required to give written notice
of same:

 

	(a)		The failure of Borrower to repay all outstanding Principal on or before the Maturity
Date or timely deliver Shares upon a Conversion;

	(b)		The failure of Borrower to promptly perform any obligation of Borrower under, a breach
of, or the existence of an Event of Default as defined in this Note, or any other note, debt or claim owed by Borrower to Lender;
or

	(c)		Borrower becomes insolvent, bankrupt or generally fails to pay its debts as such debts
become due; is adjudicated insolvent or bankrupt; admits in writing its inability to pay its debts; or shall suffer a custodian,
receiver or trustee for it or substantially all of its property to be appointed and if appointed without its consent, not
be discharged within sixty (60) consecutive days; makes an assignment for the benefit of creditors; or suffers proceedings under
any law related to bankruptcy, insolvency, liquidation or the reorganization, readjustment or the release of debtors to be instituted
against it and if contested by it not dismissed or stayed within sixty (60) consecutive days; if proceedings under any law related
to bankruptcy, insolvency, liquidation, or the reorganization, readjustment or the release of debtors is instituted or commenced
by or against Borrower; if any order for relief is entered relating to any of the foregoing proceedings; if Borrower shall call
a meeting of its creditors with a view to arranging a composition or adjustment of its debts; or if Borrower shall by any act
or failure to act indicate its consent to, approval of or acquiescence in any of the foregoing.

 

	8.		Remedies. Upon the happening and during the continuation of any Event of Default,
(i) Lender may, at its sole option, declare the entire Principal immediately due and payable in full; (ii) interest shall accrue
on all amounts due hereunder at the Default Rate until paid in full or such Event of Default is cured; and (iii) Lender shall
have and may exercise any and all rights and remedies available hereunder, at law and in equity, together with any and all rights
and remedies provided in any related document including the Mutual Release and Settlement Agreement. The acceptance of any installment
or payment after the occurrence of an Event of Default or event giving rise to the right of acceleration provided for herein shall
not constitute a waiver of such right of acceleration with respect to such Event of Default or event or any subsequent Event of
Default. The remedies of Lender, as provided herein or in any related document, shall be cumulative and concurrent, and may be
pursued singularly, successively or together, at the sole discretion of Lender, and may be exercised as often as occasion therefore
shall arise. Any act, omission or commission of Lender, including, specifically, any failure to exercise any right, remedy or
recourse, shall be released and be effected only through a written document executed by Lender and then only to the extent specifically
recited therein. A waiver or release with reference to any one event shall not be construed as continuing, as a bar to, or as
a waiver or release of, any subsequent right, remedy or recourse as to a subsequent event.

 

	9.		Collection Costs. If one or more Events of Default (or any event which with
notice or passage oftime or both would constitute an Event of Default) hereunder shall occur and continues, Borrower promises
to pay all collection costs, including but not limited to all reasonable attorneys' fees, court costs, and expenses of every kind,
incurred by Lender in connection with such collection or the protection or enforcement of any or all of the security for this
Note, whether or not any lawsuit is filed with respect thereto (including costs and reasonable attorneys' fees on any appeals
or in any bankruptcy proceedings).

 

    	4

    	 

    

 

	10.		Legal Opinions and Disclosures. Within the scope of applicable securities law
and at its cost and expense, Borrower shall cooperate to the fullest commercially reasonable extent in obtaining, or directing
its legal counsel to deliver, legal opinions or cooperate with Borrower's legal counsel pertaining to (x) the removal of restrictive
legends from Shares under Rule 144 or other applicable regulations, or (y) the deposit or new issuance of Shares by Lender to
its brokerage electronically, including such supplemental opinions as are requested by such brokerage, for any Shares issued as
a result of Conversions. All such opinions shall be delivered in not more than one (I) business day of request by Lender. In the
event Lender is required to obtain such legal opinions at its own expense, the actual and reasonable cost of same shall be added
to the Principal balance of this Note. While this Note is outstanding, Borrower shall use its commercially reasonable best efforts
to meet all requirements for providing "current information" or "fully-reporting" status as those terms are
used in the securities industry, and otherwise remain in good standing under applicable securities law, exchange rules or similar
rules or regulations, and otherwise ensure the continued tradability of its Shares.

	11.		Miscellaneous.

	(a)		Successors and Assigns. This Note inures to the benefit of Lender and its successors
or assigns, and binds Borrower, and its respective permitted successors and assigns, and the words "Lender" and "Borrower"
whenever occurring herein shall be deemed and construed to include such respective successors and assigns. Lender may assign all
or any portion of this Note without the consent of Borrower by providing written notice of such assignment.

	(b)		Severability. Any term or provision of this Note that is held by a court of
competent jurisdiction or other authority to be invalid, void or unenforceable in any situation or in any jurisdiction shall not
affect the validity or enforceability of the remaining terms and provisions or the validity or enforceability of the invalid,
void or unenforceable term or provision in any other situation or in any other jurisdiction. If the final judgment of a court
of competent jurisdiction or other authority declares that any term or provision of this Note is invalid, void or unenforceable,
the parties agree that the court making such determination shall have the power to and shall, subject to the discretion of such
court, reduce the scope, duration, area or applicability of the term or provision, to delete specific words or phrases, or to
replace any invalid, void or unenforceable term or provision with a term or provision that is valid and enforceable and that comes
closest to expressing the intention of the invalid or unenforceable term or provision.

	(c)		Waiver.
                                         To the fullest extent permitted by law, Borrower hereby waives all valuation
                                         and appraisement privileges, presentment and demand for payment, protest, notice of protest
                                         and nonpayment, dishonor and notice of dishonor, bringing of suit, lack of diligence
                                         or delays in collection or enforcement of this Note and notice of the intention to accelerate,
                                         the release of any liable party, the release of any security for the indebtedness evidenced
                                         hereby, and any other indulgence or forbearance, and is and shall be directly and primarily
                                         liable for the amount of all sums owing and to be owed hereon, and agrees that this Note
                                         and any or all payments coming due hereunder may be extended or renewed from time to
                                         time without in any way affecting or diminishing Borrower's liability hereunder.

	(d)		Notices. All notices required to be given to any of the parties hereunder shall
be in writing and shall be delivered (a) by personal delivery, with receipt acknowledged; (b) by telecopier or electronic mail
(with original copy to follow as set forth herein); (c) by reputable overnight commercial courier service; or (d) by United States
registered or certified mail, return receipt requested, postage prepaid, to the parties at the addresses as set forth below (subject
to the right of a party to designate a different address for itself by notice similarly given). Whenever the giving of notice
is required, the giving of such notice may be waived in writing by the party entitled to receive such notice.

 

    	5

    	 

    

 

If to Borrower:

VG Life Sciences Inc.

2290 Huntington Drive, Suite 100

San Marino, CA 91108

Attn: Haig Keledjian

Fax: (626) 334-5324

Email: haigq-isvglifesciences.com

If to Lender:

Michael Capizzano

c/o 2185 Warmlands Avenue

Vista, CA 92084

Fax: (416) 907-1429

Email: michae1eapizzano@gmai1.cer
or mike@c-suiteadvisors.corn

(e) Entire Agreement.
This Note contains the entire agreement between the parties with respect to the subject matter hereof and thereof.

(1) Modification of
Agreement. This Note may not be modified, altered or amended, except by an agreement in writing signed by both Borrower and
Lender.

		(g)	Releases by Borrower. Borrower hereby releases Lender from all technical and procedural
errors, defects and imperfections whatsoever in enforcing the remedies available to Lender upon a default by Borrower hereunder.

		(h)	Remedies Not Exclusive. No remedy herein conferred upon or reserved to Lender is intended
to be exclusive of any other remedy or remedies available to Lender under this Unsecured Revolving Credit Note, at law, in equity
or by statute, and each and every such remedy shall be cumulative and in addition to every other remedy given hereunder or now
or hereafter existing at law, in equity or by statute.

		(i)	Governing Law. This Note shall be governed by and construed under the laws of the State
of California without giving effect to the choice of law provisions thereof.

		(j)	Consent to Jurisdiction. Borrower hereby consents that any action or proceeding against
it may be commenced and maintained in any Federal or state court sitting in Los Angeles County, California, and that such courts
shall have jurisdiction with respect to the subject matter hereof and the person of Borrower and the collateral securing Borrower's
obligations hereunder.

		(k)	Time of Essence. Time
                                         is of the essence of this Note and all of the obligations hereunder.

	(1)		Headings. The headings of the sections of this Note are inserted for convenience
only and do not constitute a part of this Note.

	(m)		Waiver of Jury Trial. BORROWER AND LENDER, TO THE FULL EXTENT PERMITTED BY
LAW, EACH HEREBY KNOWINGLY, INTENTIONALLY AND VOLUNTARILY WAIVES, RELINQUISHES AND FOREVER FORGOES HEREBY THE RIGHT TO A TRIAL
BY JURY IN ANY ACTION OR PROCEEDING, INCLUDING, WITHOUT LIMITATION, ANY TORT ACTION, BROUGHT BY EITHER OF THEM AGAINST THE OTHER
BASED UPON, ARISING OUT OF, OR IN ANY WAY RELATING TO OR IN CONNECTION WITH THIS UNSECURED REVOLVING CREDIT Note, OR ANY COURSE
OF CONDUCT, ACT, OMISSION, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PERSON (INCLUDING, WITHOUT
LIMITATION, SUCH PERSON'S DIRECTORS, OFFICERS, PARTNERS, MEMBERS, EMPLOYEES, AGENTS OR ATTORNEYS, OR ANY OTHER PERSONS AFFILIATED
WITH SUCH PERSON), IN CONNECTION WITH THIS Note , INCLUDING, WITHOUT LIMITATION, IN ANY COUNTERCLAIM WHICH BORROWER MAY BE PERMITTED
TO ASSERT HEREUNDER OR WHICH MAY BE ASSERTED BY LENDER OR ITS AGENTS AGAINST BORROWER, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE.
THIS WAIVER BY BORROWER OF ITS RIGHT TO A JURY TRIAL IS A MATERIAL INDUCEMENT FOR LENDER UNDER THIS UNSECURED REVOLVING CREDIT
Note.

 

    	6

    	 

    

 

	n)		Note for Business
                                         or Commercial Purpose. BORROWER EXPRESSLY WARRANTS AND REPRESENTS TO LENDER THAT
                                         THIS Note IS INTENDED FOR AND WILL BE USED FOR A BUSINESS OR COMMERCIAL PURPOSE AND THAT
                                         THIS Note IS NOT INTENDED FOR A CONSUMER, PERSONAL, FAMILY OR HOUSEHOLD PURPOSE.

 

	(o)		Authority.
                                         Borrower (and the undersigned representative of Borrower, if any) represents and warrants
                                         that it has full power and authority to execute and deliver this Note, and the execution
                                         and delivery of this Note has been duly authorized and does not conflict with or constitute
                                         a default under any law, judicial order or other agreement affecting Borrower.

 

	(p)		Assignment. Lender may assign, transfer, pledge or hypothecate any or all of
this Note or the Shares acquirable upon exchange without Borrower's consent.

 

IN WITNESS WHEREOF, Borrower has executed and
delivered this Note effective as of the date first above written.

 

 

	 	BORROWER:
	 	 
	 	VG LIFE SCIENCES INC.
	 	 
	 	By: /s/ Haig Keledjian
		Haig Keledjian, President and CEO
	 	Dated: 7/12/2013

 

 

    	7

    	 

    

 

ANNEX A

 

NOTICE OF CONVERSION

 

The undersigned hereby
elects to convert principal of the Note pursuant to Section 1(b) therein into shares of common stock, par value $0.0001 per share,
of VG Life Sciences Inc., a Delaware corporation ("Shares"), according to the conditions hereof, as of the date written
below. If Shares are to be issued in the name of a person other than the Lender of the Note, such person will pay all transfer
taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Borrower
in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, if any.

 

Conversion calculations:

 

Date to Effect Conversion:

 

Principal Amount of Note to be Converted:

 

Number of shares of Common Stock to be issued:

 

Signature:

 

Name:

 

Address:

 

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]